Search filters

List of works by Camille Tlemsani

Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy

scientific article published on 6 August 2015

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals.

scientific article

Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review

scientific article

Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib

scientific article published on 25 March 2015

Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity

scientific article

Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation

scientific article published on 29 May 2015

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.

scientific article

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

scientific article published on 14 June 2019

One NF1 Mutation may Conceal Another

scientific article published on 22 August 2019

Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.

scientific article

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

scientific article published on 18 February 2020

SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort

scientific article published on 17 June 2016

[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management].

scientific article published on 29 January 2016